Then we analyzed the OS of patients with glioma, and found that the OS of patients with high IGF2BP3 expression was significantly reduced (p < 0.001) (Figure 4C), which was consistent with the results of the TCGA. Here, IGF2BP3 is linked to central nervous system cancer.